Longevity Biotech
Focus: Longevity Biotech is a Philadelphia-based public biotechnology company specializing in synthetic peptides for neurology and longevity-focused indications. The company operates in a rapidly expanding $617B longevity biotech market attracting significant investor capital.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Longevity Biotech
AI assessmentNot HiringNo open roles listed right now. Follow Longevity Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Longevity Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LBT-3627
Parkinson DiseaseClinical Trials (1)
NCT03633513Parkinson's Disease Inflammatory Biomarker Profiling
N/AHelp build intelligence for Longevity Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.